Anteris Technologies (AU:AVR) has released an update.
Anteris Technologies Global Corp. has announced the initiation of its U.S. initial public offering, aiming to list 14.8 million shares on the Nasdaq Global Market under the ticker ‘AVR’. The proceeds will support the development of its innovative DurAVR transcatheter heart valve and other corporate needs. This move positions Anteris for an expanded presence in the global financial market, potentially capturing the attention of investors interested in the medical technology sector.
For further insights into AU:AVR stock, check out TipRanks’ Stock Analysis page.